Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Corvidia revenue
Corvidia's revenue is $750,000.
What is Corvidia's revenue?
- Corvidia has 30 employees, and the revenue per employee ratio is $25,000.
- Corvidia peak revenue was $750.0K in 2024.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Corvidia financing
Corvidia received early financing of $26.0M on 2016-02-17.
| Series | Round size | Date |
|---|---|---|
| Series A | $26M | 02/2016 |
| Series B | $60M | 04/2018 |
| Convertible Note | $827K | 03/2020 |
Corvidia investors
| Investors | Security type |
|---|---|
| Apple Tree Partners | Series A |
| SOFINNOVA PARTNERS | Series A |
| HBM Healthcare Investments AG | Series B |
| Apple Tree Partners | Series B |
| ANDERA PARTNERS | Series B |
| Venrock | Series B |
| Cormorant Asset Management | Series B |
| MedImmune | Series B |
| Venrock Healthcare Capital Partners | Series B |
| Fresenius Medical Care | Series B |
| SOFINNOVA PARTNERS | Series B |
| HBM Healthcare Investments AG | Convertible Note |
Corvidia competitors
Corvidia's top competitor, XORTX Therapeutics, earned an annual revenue of $6.2B.
Corvidia's smallest competitor is Tarsa Therapeutics with revenue of $1.6M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Encoded Therapeutics | - | $5.0M | 128 | - |
| Semma Therapeutics | - | $34.9M | 75 | - |
| C4 Therapeutics | - | $35.6M | 300 | - |
| Tarsa Therapeutics | - | $1.6M | 10 | - |
| Cerecor | - | $6.7M | 32 | - |
| XORTX Therapeutics | - | $6.2B | 2 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Most in demand jobs
Zippia gives an in-depth look into the details of Corvidia, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Corvidia. The employee data is based on information from people who have self-reported their past or current employments at Corvidia. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Corvidia. The data presented on this page does not represent the view of Corvidia and its employees or that of Zippia.
Corvidia may also be known as or be related to Corvidia, Corvidia Therapeutics Inc and Corvidia Therapeutics, Inc.